López-Arribillaga, Erika
Rodilla, Verónica http://orcid.org/0000-0003-0512-4179
Colomer, Carlota
Vert, Anna
Shelton, Amy
Cheng, Jason H.
Yan, Bing
Gonzalez-Perez, Abel
Junttila, Melissa R.
Iglesias, Mar
Torres, Ferran
Albanell, Joan
Villanueva, Alberto
Bigas, Anna
Siebel, Christian W.
Espinosa, LLuís
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI16/00437)
Article History
Received: 21 December 2016
Accepted: 29 June 2018
First Online: 31 July 2018
Change Date: 3 September 2018
Change Type: Update
Change Details: This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.
Competing interests
: A.S., J.H.C., M.R.J., and C.W.S. are or were employed by Genentech Inc., which has commercial interests in some of the molecules described.